Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 4:33 pm Purchase | 2025-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | JANUS HENDERSON GROUP PLC JHG | 1,155,995 14.900% | 10,335 (+0.90%) | Filing History |
| 2026-02-17 4:22 pm Sale | 2025-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | Commodore Capital LP | 18,851 0.300% | -481,149 (-96.23%) | Filing History |
| 2026-02-17 4:00 pm Purchase | 2025-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | PERCEPTIVE ADVISORS LLC | 449,290 4.600% | 4,641 (+1.04%) | Filing History |
| 2026-02-06 3:00 pm Purchase | 2026-01-31 | 13G | Bright Minds Biosciences Inc. DRUG | Cormorant Asset Management LP | 1,059,331 10.880% | 1,059,331 (New Position) | Filing History |
| 2025-11-14 6:38 pm Purchase | 2025-09-30 | 13G | Bright Minds Biosciences Inc. DRUG | Vivo Opportunity Fund Holdings, L.P. | 454,184 6.400% | 454,184 (New Position) | Filing History |
| 2025-11-13 09:00 am Purchase | 2025-09-30 | 13G | Bright Minds Biosciences Inc. DRUG | Adage Capital Management, L.P. | 395,743 5.580% | 395,743 (New Position) | Filing History |
| 2025-11-12 08:00 am Sale | 2025-09-30 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 190,764 2.690% | -321,574 (-62.77%) | Filing History |
| 2025-08-14 10:58 am Purchase | 2025-06-30 | 13G | Bright Minds Biosciences Inc. DRUG | JANUS HENDERSON GROUP PLC JHG | 1,145,660 16.300% | 34,292 (+3.09%) | Filing History |
| 2025-08-13 2:00 pm Purchase | 2025-06-30 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 512,338 7.270% | 4,776 (+0.94%) | Filing History |
| 2025-05-15 4:51 pm Purchase | 2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG | RA CAPITAL MANAGEMENT LLC | 206,427 2.900% | 206,427 (New Position) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG | PERCEPTIVE ADVISORS LLC | 444,649 6.300% | 444,649 (New Position) | Filing History |
| 2025-04-08 3:14 pm Purchase | 2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 507,562 7.210% | 55,769 (+12.34%) | Filing History |
| 2025-04-07 4:07 pm Purchase | 2025-03-31 | 13G | Bright Minds Biosciences Inc. DRUG | JANUS HENDERSON GROUP PLC JHG | 1,111,368 16.000% | 306,392 (+38.06%) | Filing History |
| 2025-02-14 4:06 pm Purchase | 2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | Point72 Asset Management L.P. | 135,189 3.000% | 135,189 (New Position) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | Nkarta, Inc. NKTX | Commodore Capital LP | 351,848 0.500% | 351,848 (New Position) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | Celcuity Inc. CELC | Commodore Capital LP | 1,095,650 2.900% | 1,095,650 (New Position) | Filing History |
| 2025-02-14 4:05 pm Purchase | 2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | Commodore Capital LP | 500,000 7.200% | 500,000 (New Position) | Filing History |
| 2025-02-10 12:56 pm Purchase | 2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG | Sio Capital Management LLC | 451,793 6.500% | 451,793 (New Position) | Filing History |
| 2025-02-07 10:49 am Purchase | 2025-01-31 | 13G | Bright Minds Biosciences Inc. DRUG | JANUS HENDERSON GROUP PLC JHG | 804,976 11.600% | 804,976 (New Position) | Filing History |
| 2024-11-12 4:15 pm Unchanged | 2024-11-12 | 13G | Bright Minds Biosciences Inc. DRUG | RA CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |